Evidence map›Paper›PMID 33259154›Full record

ArticleThe New England journal of medicine2020

Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer.

Teresa Aydillo, Ana S Gonzalez-Reiche, Sadaf Aslam, Adriana van de Guchte, Zenab Khan, Ajay Obla, Jayeeta Dutta, Harm van Bakel, Judith Aberg, Adolfo García-Sastre and 7 more

Registry-linked trialAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in The New England journal of medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05172063 (Persistent SARS-CoV-2 Infection in Children With Cancer and Impaired Immune Responsiveness), which is not on this map. Cited by 256 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
256citing papers in PubMed, 10 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05172063 unknown statusnot on this mapstarted 2022, after this paper: background citation

Persistent SARS-CoV-2 Infection in Children With Cancer and Impaired Immune Responsiveness

TypeobservationalSponsorChildren's Cancer Hospital Egypt 57357Ran2022 to 2023Enrolled30ConditionsChildren With Cancer, SARS-CoV-2 Infection
3 · Its place in the literature

Who cites it

256 citing papers in PubMed, 10 syntheses or guidelines pooled it.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Guideline
  5. Pooled it
  6. Pooled it
  7. Guideline
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

196 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Teresa AydilloIcahn School of Medicine at Mount Sinai, New York, NY.
Ana S Gonzalez-ReicheIcahn School of Medicine at Mount Sinai, New York, NY.
Sadaf AslamIcahn School of Medicine at Mount Sinai, New York, NY.
Adriana van de GuchteIcahn School of Medicine at Mount Sinai, New York, NY.
Zenab KhanIcahn School of Medicine at Mount Sinai, New York, NY.
Ajay OblaIcahn School of Medicine at Mount Sinai, New York, NY.
Jayeeta DuttaIcahn School of Medicine at Mount Sinai, New York, NY.
Harm van BakelIcahn School of Medicine at Mount Sinai, New York, NY.
Judith AbergIcahn School of Medicine at Mount Sinai, New York, NY.
Adolfo García-SastreIcahn School of Medicine at Mount Sinai, New York, NY.
Gunjan ShahMemorial Sloan Kettering Cancer Center, New York, NY kambojm@mskcc.org.
Tobias HohlMemorial Sloan Kettering Cancer Center, New York, NY kambojm@mskcc.org.
Genovefa PapanicolaouMemorial Sloan Kettering Cancer Center, New York, NY kambojm@mskcc.org.
Miguel-Angel PeralesMemorial Sloan Kettering Cancer Center, New York, NY kambojm@mskcc.org.
Kent SepkowitzMemorial Sloan Kettering Cancer Center, New York, NY kambojm@mskcc.org.
N Esther BabadyMemorial Sloan Kettering Cancer Center, New York, NY kambojm@mskcc.org.
Mini KambojMemorial Sloan Kettering Cancer Center, New York, NY kambojm@mskcc.org.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
T LYMPHOCYTE SUBSET FUNCTION POST-TRANSPLANTATIONP01CA023766 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SCHEINBERG, DAVID A · 1985 to 2023
$59.0M
Big Omics Data Engine 2 SupercomputerS10OD026880 · OD · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KOVATCH, PATRICIA · 2019 to 2019
$2.0M
Transforming Genomics with 5 PB Big Omics Data Engine Cray CS300-AC SupercomputerS10OD018522 · OD · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KOVATCH, PATRICIA · 2014 to 2014
$1.9M
CSR NIH HHS numbers S10OD018522 and S10OD026880CSR NIH HHS P01 CA23766Division of Intramural Research, National Institute of Allergy and Infectious Diseases CEIRS, contract # HHSN272201400008CJPB Foundation 2020-215611 (5384)NCI NIH HHS P01 CA023766NCI NIH HHS P30 CA008748NIAID NIH HHS HHSN272201400008CNIH HHS S10 OD018522NIH HHS S10 OD026880
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Immunosuppression TherapyVirus SheddingAdultAgedCOVID-19FemaleHematopoietic Stem Cell TransplantationHumansMaleMiddle AgedNeoplasms

Identifiers

PMID33259154
PMCPMC7722690

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.